際際滷

際際滷Share a Scribd company logo

Prevention of Sudden Cardiac Death with Implantable Cardiac Defibrillators in Children and Adolescents with Hypertrophic Cardio Myopathy

Download as PPTX, PDF
J
Jennifer Glen

Student Biology Seminar Class presentation based on peer reviewed journal that breaks down the journal in various components for a more elusive understanding on whether Implantable Cardioverter- defibrillators provides efficacy for young children with heart conditions that lead up to Sudden Cardiac Death.

1 of 23
Downloaded 39 times
Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillators in Children and Adolescents With Hypertrophic Cardiomyopathy Presented By: Jennifer Glen, Mi Hae Kim, Rosangel Vargas
Overview Objectives Background Methods Results Conclusion Critiques Q&A
Objective To determine the efficacy of ICDs in children and adolescents with HCM
Background What is HCM? HCM is the most common cause of SD in children and young adults
Implantable Cardioverter Defibrillator (ICD)
Types of ICDs
Prevention of Sudden Cardiac Death with Implantable Cardiac Defibrillators in Children and Adolescents with Hypertrophic Cardio Myopathy
Abbreviations and Acronyms HCM - Hypertrophic Cardiomyopathy ICD - Implantable Cardioverter Defibrillator LV - Left Ventricle LVH - Left Ventricular Hypertrophy SD - Sudden Death VF - Ventricular Fibrillation VT - Ventricular Tachycardia
Methods Patient Selection Defibrillators Risk Factor Analysis
Results Baseline Characteristics ICD interventions /Timing Drugs Risk Factor Analysis
Prevention of Sudden Cardiac Death with Implantable Cardiac Defibrillators in Children and Adolescents with Hypertrophic Cardio Myopathy
Prevention of Sudden Cardiac Death with Implantable Cardiac Defibrillators in Children and Adolescents with Hypertrophic Cardio Myopathy
Prevention of Sudden Cardiac Death with Implantable Cardiac Defibrillators in Children and Adolescents with Hypertrophic Cardio Myopathy
Prevention of Sudden Cardiac Death with Implantable Cardiac Defibrillators in Children and Adolescents with Hypertrophic Cardio Myopathy
Prevention of Sudden Cardiac Death with Implantable Cardiac Defibrillators in Children and Adolescents with Hypertrophic Cardio Myopathy
Prevention of Sudden Cardiac Death with Implantable Cardiac Defibrillators in Children and Adolescents with Hypertrophic Cardio Myopathy
Discussion History of HCM Studies In this study o Children and Adolescents ( < 20 years ) o Effective 20 % ( 90% with No or mild Symptoms) Who gets ICD among HCM patients o Extreme LVH o Syncope o Family History o Hypotensive BP response to exercise
Prevention of Sudden Cardiac Death with Implantable Cardiac Defibrillators in Children and Adolescents with Hypertrophic Cardio Myopathy
Prevention of Sudden Cardiac Death with Implantable Cardiac Defibrillators in Children and Adolescents with Hypertrophic Cardio Myopathy
Conclusion Successful ! Pros and Cons
Critiques Data Words
Reference Maron BJ, Spirito P, Ackerman MJ, Casey SA,Semsarian C, Estes M, Shannon KM, Ashley EA, Day SM, Pacileo G, Formisano F, Devoto E, Anastasakis A, Bos JM, Woo A, Autore C, Pass RH, Boriani G, Garberich RF, Almquist AK, Russell MW, Boni L, Berger S, Maron MS,Link MS. 2013. Prevention of Sudden Cardiac Death With Implantable Cardioverter- Defilbrillators in Children and Adolescents With Hypertrophic Cardiomyopathy. Journal of American College of Cardiology (No.14) [Internet]. [2013 April 09, cited 2015 March 13] Vol. 61. Available from: http://content.onlinejacc.org/mobile/article.aspx?articleid=1673454
Questions?

More Related Content

Prevention of Sudden Cardiac Death with Implantable Cardiac Defibrillators in Children and Adolescents with Hypertrophic Cardio Myopathy

  • 1. Prevention of Sudden Cardiac Death With Implantable Cardioverter-Defibrillators in Children and Adolescents With Hypertrophic Cardiomyopathy Presented By: Jennifer Glen, Mi Hae Kim, Rosangel Vargas
  • 2. Overview Objectives Background Methods Results Conclusion Critiques Q&A
  • 3. Objective To determine the efficacy of ICDs in children and adolescents with HCM
  • 4. Background What is HCM? HCM is the most common cause of SD in children and young adults
  • 8. Abbreviations and Acronyms HCM - Hypertrophic Cardiomyopathy ICD - Implantable Cardioverter Defibrillator LV - Left Ventricle LVH - Left Ventricular Hypertrophy SD - Sudden Death VF - Ventricular Fibrillation VT - Ventricular Tachycardia
  • 9. Methods Patient Selection Defibrillators Risk Factor Analysis
  • 10. Results Baseline Characteristics ICD interventions /Timing Drugs Risk Factor Analysis
  • 17. Discussion History of HCM Studies In this study o Children and Adolescents ( < 20 years ) o Effective 20 % ( 90% with No or mild Symptoms) Who gets ICD among HCM patients o Extreme LVH o Syncope o Family History o Hypotensive BP response to exercise
  • 20. Conclusion Successful ! Pros and Cons
  • 22. Reference Maron BJ, Spirito P, Ackerman MJ, Casey SA,Semsarian C, Estes M, Shannon KM, Ashley EA, Day SM, Pacileo G, Formisano F, Devoto E, Anastasakis A, Bos JM, Woo A, Autore C, Pass RH, Boriani G, Garberich RF, Almquist AK, Russell MW, Boni L, Berger S, Maron MS,Link MS. 2013. Prevention of Sudden Cardiac Death With Implantable Cardioverter- Defilbrillators in Children and Adolescents With Hypertrophic Cardiomyopathy. Journal of American College of Cardiology (No.14) [Internet]. [2013 April 09, cited 2015 March 13] Vol. 61. Available from: http://content.onlinejacc.org/mobile/article.aspx?articleid=1673454